Bladder perivascular epithelioid cell tumors by Tricard, T. et al.
African Journal of Urology (2018) 24, 163–168
African  Journal  of  Urology
Official journal of the Pan African Urological Surgeon’s Association





Bladder  perivascular  epithelioid  cell  tumors
T.  Tricard a,∗,  S.  Lopez a,  V.  Lindner b,  J.-L.  Jung a
a Department  of  Urology,  Hôpitaux  Civil  de  Colmar,  39  Avenue  de  la  liberté,  Colmar,  France
b Department  of  Pathology,  Hôpital  de  Hautepierre,  1  Avenue  Molière,  Strasbourg,  France









Introduction:  Perivascular epithelioid cell tumors (PEComas) of the bladder are infrequent localisation of
this mesenchymal cancer with uncertain malignant behavior.
Case  report:  We report the case of a 74 years old women who was diagnosed a malignant PEComa of the
bladder. She necessited radical cystectomy with orthotopic ileocaecal pouch reconstruction. Histology and
immunohistochemistry confirmed the diagnosis of a malignant PEComa of the bladder. We evaluate the
literature cases to adjust the prognosis criteria.
Conclusion:  Evolution and prognosis evaluation remain hard and could necessitate a radical surgery. Prog-
nosis criteria for the bladder PEComas have to be clarified.
© 2018 Pan African Urological Surgeons Association. Production and hosting by Elsevier B.V. This is an open










Perivascular epithelioid cell sarcomas (PEComas) are a rare type
of mesenchymal tumors with an unpredictable evolution. PECo-
mas were introduced by Zamboni et al. [1] for mesenchymatous
tumors that include angiomyolipoma, clear cell sugar tumor and
lymphangioleiomyomatosis. These lesions have different clinical
characteristics and appeared sporadically or in a Bourneville’s tuber-
ous sclerosis syndrome [1–3]. PEComas occur frequently in women
between 50 and 60 years old. Soft tissues are the most common local-∗ Corresponding author.
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2–8].
EComas are composed of epithelioid, fusiform, eosinophil or clear
ell that express melanocytic or smooth muscular markers [1].
espite improvement of diagnosis (histological and immunohisto-
hemical criteria), evolution and prognosis evaluation remain hard.
nalysis of literature review is difficult because of a small num-
er of cases reported and the short time of follow-up. Most of the
ases are benign but few cases of malignant PEComas have been




















































igure  1  Mass of the left-postero lateral wall of the bladder on CT-
can.
e report a case of a woman of 74 affected by a malignant
EComa of the bladder which was successfully treated by radical
ystectomy.
ase  report
 74-year-old woman had a single episode of hematuria, the uro-
ogical tomodensitometry revealed a mass of the left-postero lateral
all of the bladder (Fig. 1). The cystoscopy confirms the presence
f the 2-cm tumor, the cytology was normal. Pelvic MRI showed a
-cm undefined lesion between vagina and bladder (Fig. 2).
athological examination of the bladder’s transurethral resection
evealed a neoplastic proliferation based on abundant cytoplas-
ic cells and vesiculous chromatin nucleus without necrosis or
ngio-invasion. Immunohistochemical studies were performed on
ormalin-fixed paraffin-embedded tissue using antibodies directed
gainst Melan-A (A103, 1:25, Dako Agilent, Santa Clara, USA),
MB45 (HMB45, Dako, 1:50), smooth muscle   actin (1A4, 1:50;
ako), desmin (NCL-DER11, prediluted, Ventana Roche Medical
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ystems, Tucson, USA), pS-100 (EP-32, 1/400, Clinisciences, Nan-
erre, France), and TFE3 (MRQ-37, prediluted, Ventana Roche).
ppropriate positive and negative controls were employed. This
mmunohistochemical study was realized on Ventana Roche Bench-
ark XT with an antigen retrieval process, in a EDTA citrate buffer
pH 8,3) during 30 mn or 60 mn depending of the antibodies (mild or
tandard cell conditioning, CC1, Ventana Roche), followed by incu-
ation with the different antibody and via the ultraView Universal
AB Detection Kit (Ventana Roche).
hese lesion invaded muscle and chorion but bladder mucosa
eemed to be respected. Immunohistochemically, the tumor cells
emonstrated strong positivity for HMB45 (cytoplasmic), CD68
cytoplasmic) and TFE3 (nucleus) antibodies, with focal staining by
esmin. The neoplastic cells failed to stain with antibodies against
imentin, Melan-A, PS100, smooth muscle actin and epithelial
arkers: diagnosis of PEComa with uncertain malignant potential
as suggested (Fig. 3).
adical cystectomy with orthotopic ileocaecal pouch reconstruction
as performed without any complication and patient was discharged
n day 10. Pathological examination confirmed PEComa diagnosis
ith positivity for HMB45 and TFE3 and negativity for Melan-A
nd Desmin. Mitotic rate (3/50 HPF) with abnormal mitotic figures,
igh nuclear grade and hyper cellularity were in favor of a malignant
otential of this PEComa (Fig. 4).
iscussion
he World Health Organization defines PEComas as mesenchy-
al tumors composed of histologically and immunohistochemically
istinctive perivascular epithelioid cells [2]. Main differential diag-
osis are renal carcinoma metastasis, adrenocortical carcinoma and
pithelioid sarcomas.
hile PEComas have been described many times in gyneco-
ogic tract, retroperitoneum, gastrointestinal tract, pancreas, liver,
allbladder, bones and soft tissues, oro-nasopharyngeal tract, peri-
ardium, few publications reported it for urologic localization.
n the genitourinary tract, PEComas have been described in the
idney [9–13], bladder [7,13–25] (Table 1), prostate [7,25]. Clinical
resentation of bladder PEComas are variable in the literature from
bdominal pain to hematuria mimicking an urothelial carcinoma.
ue to the lack of evidence proof and limited follow-up, it’s hard to
ssess the prognosis of the bladder PEComa. While majority of the
eported cases seemed to have benign behavior, some of them were
ggressive tumors leading to local recurrences, metastasis and death
f the patient, attesting the necessity of an accurate identification and
herapeutic strategy.
iagnosis of bladder PEComas is rare and may be underestimated
ecause of a lack of awareness of both urologist and pathologist
ommunity. We think that this pathology has to be known as a dif-
erential diagnosis of urothelial carcinoma to allow a much more
ccurate treatment for the patient.atients’ follow-up remains critical even after complete resec-
ion or benign tumor. In our opinion, bi-annual examination and
horacic-abdominal-pelvic computed tomography scan, associated










Table  1  Review of bladder PECOMA publications.




[7] Pan CC Clear cell myomelanocytic tumor of the
urinary bladder.
Am J Surg Pathol 2003 1 Case report
[25] Kalyanasundaram K Perivascular epithelioid tumor of urinary
bladder and vagina.
Ann Diagn Pathol 2005 1 Case report
[20] Parfitt JR Primary PEComa of the bladder treated with
primary excision and adjuvant
interferon-alpha immunotherapy: a case
report.
BMC Urol 2006 1 Case report
[24] Weinreb I Perivascular epithelioid cell neoplasms
(PEComas): four malignant cases expanding
the histopathological spectrum and a
description of a unique finding.
Virchows Arch Int J
Pathol
2007 1 Case report
[21] Sukov WR Perivascular epithelioid cell tumor
(PEComa) of the urinary bladder: report of 3
cases and review of the literature.
Am J Surg Pathol 2009 3 Case series
[13] Wang G Perivascular epithelioid cell tumor of urinary




2012 1 Case report
[18] Yin L Perivascular epithelioid cell neoplasm of the
urinary bladder in an adolescent: a case
report and review of the literature.
Diagn Pathol 2012 1 Case report
[19] Kyrou D Bladder perivascular epithelioid cell tumor: a
novel rare neoplasm.
Urol Int 2012 1 Case report
[23] Shringarpure SS PEComa of the urinary bladder. Saudi J Kidney Dis
Transplant
2012 1 Case report
[16] Abou Ghaida R Bladder perivascular epithelioid cell tumors. BMJ Case Rep 2013 1 Case report
[17] Williamson SR Malignant perivascular epithelioid cell
neoplasm (PEComa) of the urinary bladder
with TFE3 gene rearrangement:
clinicopathologic, immunohistochemical,
and molecular features.
Am J Surg Pathol 2013 1 Case report
[22] Sendo H A case of gallbladder metastasis from a
malignant perivascular epithelioid cell tumor
of the bladder.
Jpn J Gastro-Enterol 2013 1 Case report
[14] Tarplin S Perivascular epithelioid cell tumor of the
bladder.
BMJ Case Rep 2014 1 Case report
[15] Russell CM Perivascular epithelioid cell tumor
(PEComa) of the urinary bladder associated
with Xp11 translocation.
Ann Clin Lab Sci 2014 1 Case report
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Figure  3  Neoplastic cells positives to HMB45 markers and negatives for Caldesmon markers (×40).
Table  2  Folpe’s classification of PEComas [27].
Criteria Percentage fulfilling criteria
with aggressive behavior
Comment
Benign No worrisome features 0 of 22 (22%)
(<5 cm, non-infiltrative, non-high nuclear
grade and cellularity, mitotic rate ≤ 1/50




giant cells only or
1) 0 of 6 (0%) 1) “Symplastic”
PEComa-probably benign,
but few reported cases
2) Size >5 cm only 2) 2 of 17 (12%) 2) Large tumors should be
extensively sampled to
exclude areas with other
worrisome features
Malignant Two or more worrisome features 12 of 17 (71%)


















cellularity, mitotic rate ≥ 1/50 HPF, necros
vascular invasion)
rovided during 5 years. However, pelvic MRI and bone scan should
e reserved for elective suspicious cases.
rognosis criteria proposed by Eken et al. [26] were based on soft
issues and gynecologic tract PEComas: size, infiltrative status, cel-
ularity, mitotic rate, necrosis and vascular invasion (Table 2).
his classification seems to be inappropriate for bladder PECo-
as because of the risk of sub-staging. Despite a few number of
eported case about aggressive PEComas, we think that the clinical
resentation is a very important feature to presume of the behav-
or of the tumor: hematuria or indirect sign of fistula (digestive or
ynecologic) may be a sign of aggressive trend (Table 3).
ccording to our experience and the literature, a size of tumor less
han 5 cm does not presume of the benign behavior especially as
ematuria was present. We believe that treatment of bladder PECo-
as have to be radical (partial or total cystectomy depending on
umor size) anytime behavior remains unclear, transurethral resec-
Figure  4  Neoplastic infiltration into muscle and superficial perivesi-
cal fat, with perineural invasion (×40).
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Table  3  Review of characteristics of aggressive bladder PEComas.
Russel et al. [15] Williamson et al. [17] Parfitt et al. [20] Our case
Clinical presentation Hematuria Hematuria Enterovesical fistula Hematuria
Size 4,2 cm 5 cm 3 cm 3 cm
Infiltrative status + + + +
Hyper-cellularity + + − +







Necrosis − + 
Vascular infiltration − + 
tion should be reserved for benign behavior (without any worrisome
features).
Conclusion
Perivascular epithelioid cell sarcomas constituted a heterogeneous
family of tumors located in all the body. During the last 10 years,
only 20 bladder PEComas were reported.
Evolution and prognosis evaluation remain hard and could necessi-
tate a radical surgery.
Prognosis criteria for the bladder PEComas have to be clarified to
adjust the treatment for this specific localization. Long time follow-
up has to be reported to define the surveillance modalities.
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